BioCentury
ARTICLE | Company News

J&J cuts bonuses following 'mixed' 2012 performance

March 15, 2013 12:30 AM UTC

Johnson & Johnson (NYSE:JNJ) reduced 2012 performance bonuses for executive officers, including Chairman and CEO Alex Gorsky, by 10% following the pharma's "mixed" performance during the year. The pharma said the bonus cuts were made to "recognize the mix of short-term successes and disappointments" in 2012, though J&J did note that its successes for the year included the number of new medicines approved. ...